Dr. Serber will advance the biotechnology enabling ArkeaBio’s first-of-its-kind solution to deliver a practical, cost-effective way for farmers and producers to reduce emissions and enhance livestock productivity. Dr. Serber’s appointment comes as ArkeaBio accelerates toward product validation and commercial deployment. BOSTON, MA, USA — ArkeaBio, a global agricultural bioscience company … [continued]
The post ArkeaBio Appoints Dr. Zach Serber as Chief Technology Officer to Accelerate Development of Methane-Reducing Livestock Vaccine appeared first on CleanTechnica.
